Risedronate Attenuates Podocyte Injury in Phosphate Transporter-Overexpressing Rats
Osteoporosis patients with chronic kidney disease (CKD) are becoming common in our superaging society. Renal dysfunction causes phosphorus accumulation in the circulating plasma and leads to the development of CKD-mineral bone disorder (MBD). We have previously reported that type III Pi transporter-...
Saved in:
Main Authors: | Yohei Asada, Takeshi Takayanagi, Tsukasa Kawakami, Eisuke Tomatsu, Atsushi Masuda, Yasumasa Yoshino, Sahoko Sekiguchi-Ueda, Megumi Shibata, Tomihiko Ide, Hajime Niimi, Eishin Yaoita, Yusuke Seino, Yoshihisa Sugimura, Atsushi Suzuki |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2019-01-01
|
Series: | International Journal of Endocrinology |
Online Access: | http://dx.doi.org/10.1155/2019/4194853 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
THE EFFECTIVENESS OF ZINC AND RISEDRONATE ON BONE TURNOVER IN RAT MODEL OF OSTEOPOROSIS ASSESSED WITH THE EXPRESSION OF β-CROSSLAPS
by: Adam Fajar, et al.
Published: (2019-12-01) -
Quantifying Podocyte Number in a Small Sample Size of Glomeruli with CUBIC to Evaluate Podocyte Depletion of db/db Mice
by: Jiaoyu Shi, et al.
Published: (2023-01-01) -
The ADF/Cofilin-Pathway and Actin Dynamics in Podocyte Injury
by: Beina Teng, et al.
Published: (2012-01-01) -
Research Progress on the Pathological Mechanisms of Podocytes in Diabetic Nephropathy
by: Lili Zhang, et al.
Published: (2020-01-01) -
Immunomodulatory Effect of Bisphosphonate Risedronate Sodium on CD163+ Arginase 1+ M2 Macrophages: The Development of a Possible Supportive Therapy for Angiosarcoma
by: Taku Fujimura, et al.
Published: (2013-01-01)